JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)

CNY 9.85

(0.92%)

Operating Expenses Summary of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest annual operating expenses in 2023 was 614.32 Million CNY , down -9.41% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest quarterly operating expenses in 2024 Q3 was 174.79 Million CNY , up 18.29% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a annual operating expenses of 595.3 Million CNY in annual operating expenses 2022, up 11.54% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a annual operating expenses of 533.7 Million CNY in annual operating expenses 2021, down -11.84% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a quarterly operating expenses of 117.53 Million CNY for 2024 Q1, down -32.82% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a quarterly operating expenses of 174.79 Million CNY for 2024 Q3, up 18.29% from previous quarter.

Annual Operating Expenses Chart of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Historical Annual Operating Expenses of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Year Operating Expenses Operating Expenses Growth
2023 614.32 Million CNY -9.41%
2022 595.3 Million CNY 11.54%
2021 533.7 Million CNY -11.84%
2020 605.34 Million CNY -3.57%
2019 627.77 Million CNY -1.87%
2018 639.73 Million CNY 25.63%
2017 509.21 Million CNY 30.53%
2016 390.1 Million CNY 27.27%
2015 306.52 Million CNY -1.26%
2014 310.43 Million CNY -8.1%
2013 337.78 Million CNY 9.95%
2012 307.22 Million CNY 17.4%
2011 261.68 Million CNY 2.77%
2010 254.63 Million CNY 17.22%
2009 217.23 Million CNY 9.19%
2008 198.95 Million CNY 15.05%
2007 172.93 Million CNY 10.68%
2006 156.23 Million CNY 11.07%
2005 140.67 Million CNY 1.86%
2004 138.11 Million CNY 1.14%
2003 136.55 Million CNY 39.81%
2002 97.67 Million CNY 15.55%
2001 84.53 Million CNY 103.86%
2000 41.46 Million CNY 25.5%
1999 33.04 Million CNY 62.75%
1998 20.3 Million CNY 10.23%
1997 18.41 Million CNY 5.54%
1996 17.45 Million CNY 0.0%

Peer Operating Expenses Comparison of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Beijing Tiantan Biological Products Co., Ltd. 824.72 Million CNY 25.511%
Jinyu Bio-technology Co., Ltd. 630.76 Million CNY 2.607%
Vcanbio Cell & Gene Engineering Corp., Ltd 953.58 Million CNY 35.577%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 1.38 Billion CNY 55.537%
Zhejiang Ausun Pharmaceutical Co., Ltd. 158.79 Million CNY -286.879%
DaShenLin Pharmaceutical Group Co., Ltd. 7.17 Billion CNY 91.439%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 3.13 Billion CNY 80.416%
GuiZhou SanLi Pharmaceutical Co.,Ltd 861.16 Million CNY 28.663%
Pulike Biological Engineering, Inc. 571.28 Million CNY -7.535%
Beijing Konruns Pharmaceutical Co.,Ltd. 675.67 Million CNY 9.08%
Shanghai Hile Bio-Technology Co., Ltd. 68.54 Million CNY -796.205%
Qingdao Vland Biotech INC. 431.31 Million CNY -42.432%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 422.38 Million CNY -45.441%
Aurisco Pharmaceutical Co.,Ltd. 375.24 Million CNY -63.713%
Zhejiang East Asia Pharmaceutical Co., Ltd. 211.78 Million CNY -190.078%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 860.45 Million CNY 28.604%
Mabwell (Shanghai) Bioscience Co., Ltd. 1.17 Billion CNY 47.896%
Beijing Hotgen Biotech Co., Ltd. 314.19 Million CNY -95.523%
Assure Tech (Hangzhou) Co., Ltd. 36.27 Million CNY -1593.399%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 399.61 Million CNY -53.73%
Cabio Biotech (Wuhan) Co., Ltd. 106.55 Million CNY -476.531%
Shanghai Shen Lian Biomedical Corporation 177.43 Million CNY -246.228%
Nanjing Vazyme Biotech Co., Ltd. 1.01 Billion CNY 39.392%
Shandong Kexing Bioproducts Co,.Ltd 1.12 Billion CNY 45.21%
Shanghai Junshi Biosciences Co., Ltd. 3.21 Billion CNY 80.878%
Shanghai Model Organisms Center, Inc. 182.57 Million CNY -236.476%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 710.45 Million CNY 13.531%
Xiamen Amoytop Biotech Co., Ltd. 1.27 Billion CNY 51.872%
Novogene Co., Ltd. 640.67 Million CNY 4.112%
Shanghai ZJ Bio-Tech Co., Ltd. 141.69 Million CNY -333.547%
Chengdu Olymvax Biopharmaceuticals Inc. 461.02 Million CNY -33.253%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 545.28 Million CNY -12.661%
Shanghai Haohai Biological Technology Co., Ltd. 1.45 Billion CNY 57.778%
Jiangsu Bioperfectus Technologies Co., Ltd. 622.73 Million CNY 1.351%
Jiangsu Aidea Pharmaceutical Co., Ltd. 258.4 Million CNY -137.738%
Chengdu Easton Biopharmaceuticals Co., Ltd. 652.1 Million CNY 5.794%
Sinocelltech Group Limited 1.77 Billion CNY 65.364%
Wuhan Keqian Biology Co.,Ltd 307.99 Million CNY -99.459%
Shanghai Allist Pharmaceuticals Co., Ltd. 1.28 Billion CNY 52.104%
Anhui Huaheng Biotechnology Co., Ltd. 274.4 Million CNY -123.873%
Youcare Pharmaceutical Group Co., Ltd. 2.39 Billion CNY 74.383%
Jiangsu gdk Biotechnology Co., Ltd. 186.4 Million CNY -229.562%
Beijing Kawin Technology Share-Holding Co., Ltd. 1 Billion CNY 39.108%
Hangzhou Biotest Biotech Co.,Ltd. 105.69 Million CNY -481.219%